1)Takase R, Otsuka F, et al : X-linked hypophosphatemia (XLH) mimicking rheumatic disease. Intern Med 59(9) : 1233-1234, 2020. PMID 31956205
2)Dennis M, et al. 2015/内藤俊夫(監訳):身体所見のメカニズム—A to Zハンドブック,原著2版.丸善出版,2019.
3)日本内分泌学会,他(編):内分泌代謝・糖尿病内科領域専門医研修ガイドブック.診断と治療社,2023.
4)Walton RJ, et al : Nomogram for derivation of renal threshold phosphate concentration. Lancet 2(7929) : 309-310, 1975. PMID 50513
5)道上敏美:Ⅲ.低リン血症・骨軟化症—2.X染色体性低リン血症性骨軟化症.日内会誌 96(4) : 725-730,2007.
[Internet]. University of Washington, Seattle, Created 2012 (Updated 2017). https://www.ncbi.nlm.nih.gov/books/NBK83985/(2023年12月13日現在)
7)Insogna KL, et al : A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia; week 24 Primary Analysis. J Bone Miner Res 33(8) : 1383-1393, 2018. PMID 29947083